Additionally, the blocking of BMX has been proven to boost the efficacy of chemotherapeutic agents by promoting BAK activation, causing tumor cells to become highly responsive to otherwise non-lethal doses of clinically important chemotherapeutic agents [1]. The gene discussed is BMX; the disease is neoplasm.